Applied Biosystems, a division of Life Technologies Corporation, introduced a new line of genotyping assays that enable researchers to study more closely the significant role that DNA copy number structural variation plays in human health and disease. The TaqMan Copy Number Assays are designed to detect and quantify copy number variations (CNVs). These assays will enable pharmaceutical, clinical, and academic researchers to accurately detect CNVs, which are changes in the number of copies of a gene, a part of a gene, or a large stretch of DNA that occur throughout a genome.
The TaqMan Copy Number Assay solution consists of more than 1.6 million pre-designed TaqMan Copy Number Assays, and Custom TaqMan Copy Number Assays, which allow researchers to detect CNVs in a specific gene or genomic region if that assay is not available in the pre-designed set.
